Ignite Creation Date:
2024-05-06 @ 12:59 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03901339
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2019-03-26
Brief Title:
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physicians Choice in Participants With HRHER2- Metastatic Breast Cancer
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-20
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-26
First Submit QC Date:
April 1 2019
Study First Post Date:
2019-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-25
Last Update Post Date:
2023-11-18
Last Update Post Date Type:
ACTUAL